Calmare Therapeutics Incorporated (OTCMKTS:CTTC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Principal Officers; Election
of Directors; Appointment of Principal Officers.
On March 18, 2017, Stan Yarbro was removed as a director
(Director) of Calmare Therapeutics, Inc. (the Company) by a
majority vote of the Board of Directors to a duly called special
meeting of the Board of Directors. Per Article II, Section 2.11
of the Bylaws of the Company, except as may otherwise be provided
by the Delaware General Corporation Law, any director of the
Corporation may be removed by a vote of a majority of the Board
of Directors in the event such Director has violated his or her
fiduciary duties to the Corporation or has violated the Corporate
Code of Conduct as then in effect.
About Calmare Therapeutics Incorporated (OTCMKTS:CTTC)
Calmare Therapeutics Incorporated (CTI) is a medical device company. The Company is engaged in developing and commercializing products and technologies for chronic neuropathic pain and wound care affliction patients. The Company’s medical device, the Calmare Pain Therapy Device (the Calmare Device), is a non-invasive and non-addictive modality that can treat chronic, neuropathic pain. The Company offers a portfolio of technologies in life, electronic, nano and physical sciences. The Company’s technology portfolio includes CALMARE pain therapy treatment, neuroprotection and cognitive enhancement, sexual dysfunction therapeutic, skin pigment enhancer, wound sealant, preparation of ordered multi-layer films, silica thin films, structural steel fissure detection paint, public key encryption, growing single crystals, and video compression and moving picture experts group (MPEG)-4. The Company’s subsidiary is Vector Vision, Inc. Calmare Therapeutics Incorporated (OTCMKTS:CTTC) Recent Trading Information
Calmare Therapeutics Incorporated (OTCMKTS:CTTC) closed its last trading session down -0.026 at 0.104 with 12,884 shares trading hands.
